MERIT MEDICAL SYSTEMS, INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1987-07-28
- Employees
- 6.9K
- Market Cap
- -
- Website
- http://www.merit.com
Clinical Trials
30
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (14 trials with phase data)• Click on a phase to view related trials
WRAP North America
- Conditions
- Venous StenosisVenous Occlusion
- First Posted Date
- 2025-02-04
- Last Posted Date
- 2025-10-03
- Lead Sponsor
- Merit Medical Systems, Inc.
- Target Recruit Count
- 250
- Registration Number
- NCT06807099
- Locations
- 🇨🇦
University Health Network, Toronto, Ontario, Canada
🇺🇸Medical University of South Carolina, Orangeburg, South Carolina, United States
🇺🇸Bluff City Vascular, Memphis, Tennessee, United States
PREEMIE: Study for Treatment of PDA in Premature Infants
- Conditions
- Patent Ductus Arteriosus (PDA)
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-08-11
- Lead Sponsor
- Merit Medical Systems, Inc.
- Target Recruit Count
- 55
- Registration Number
- NCT06587282
- Locations
- 🇺🇸
UC Davis Health, Sacramento, California, United States
🇺🇸UC San Diego-Rady Children's Hospital, San Diego, California, United States
🇺🇸Memorial Healthcare System-Joe DiMaggio Children's Hospital, Hollywood, Florida, United States
PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis
- Conditions
- End Stage Renal DiseaseHemodialysis Access Failure
- First Posted Date
- 2024-05-21
- Last Posted Date
- 2025-08-05
- Lead Sponsor
- Merit Medical Systems, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT06422871
- Locations
- 🇺🇸
Sarasota Memorial Health Care System, Sarasota, Florida, United States
🇺🇸WakeMed, Raleigh, North Carolina, United States
🇺🇸Baylor Scott & White Heart and Vascular Hospital - Dallas, Dallas, Texas, United States
Bearing nsPVA Embolization for Uterine Artery Embolization (BETTER-UAE)
- Conditions
- Uterine Fibroid
- First Posted Date
- 2023-12-01
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- Merit Medical Systems, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT06153667
- Locations
- 🇦🇺
The Alfred Health, Sydney, Australia
GAE Using Embosphere Microspheres vs Corticosteroid Injections for Treatment of Symptomatic Knee OA (MOTION)
- Conditions
- Knee Osteoarthritis
- Interventions
- Device: Embosphere MicrospheresDrug: Corticosteroid injection
- First Posted Date
- 2023-04-18
- Last Posted Date
- 2025-10-24
- Lead Sponsor
- Merit Medical Systems, Inc.
- Target Recruit Count
- 264
- Registration Number
- NCT05818150
- Locations
- 🇺🇸
Memorial Care Long Beach Medical Center, Long Beach, California, United States
🇺🇸Biotech Clinical Research/ Georgia Vascular Institute, College Park, Georgia, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
News
GORE VIABAHN FORTEGRA Venous Stent Achieves 83.4% Primary Patency in Deep Venous Obstruction Trial
The VIAFORT trial, the first prospective study to include inferior vena cava, iliac, and femoral veins, enrolled 89 patients with thrombotic disease and achieved an 83.4% primary patency rate at 12 months.
Merit Medical Enrolls First Patient in WRAPSODY Registry for Hemodialysis Vascular Access
Merit Medical Systems has enrolled the first patient in its WRAP North America registry, a prospective multicenter study designed to collect real-world safety and effectiveness data on the WRAPSODY Cell-Impermeable Endoprosthesis for hemodialysis patients.